Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ilana Chefetz, Ayesha Alvero, Jennie Holmberg, Noah Lebowitz, Vinicius Craveiro, Yang Yang-Hartwich, Gang Yin, Lisa Squillace, Marta Gurrea Soteras, Paulomi Aldo & Gil Mor. (2013) TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence. Cell Cycle 12:3, pages 511-521.
Read now
Read now
Articles from other publishers (38)
Nicola Cirillo. (2023) The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer. International Journal of Molecular Sciences 24:21, pages 15812.
Crossref
Crossref
Jingchun Chen, Lingyun Xu, Xindi Li & Seungman Park. (2023) Deep learning models for cancer stem cell detection: a brief review. Frontiers in Immunology 14.
Crossref
Crossref
Zhen Zhang, Hong Zhao, Chu Chu, Xiaoxiao Fu, Yonglin Liu, Li Wang, Ran Wei, Ke Xu, Lihua Li & Xia Li. (2022) The emerging roles of TLR and cGAS signaling in tumorigenesis and progression of ovarian cancer. Frontiers in Pharmacology 13.
Crossref
Crossref
Jacek R. Wilczyński & Marek Nowak. 2022. Interaction of Immune and Cancer Cells. Interaction of Immune and Cancer Cells
1
57
.
Mikhail S. Chesnokov, Imran Khan, Yeonjung Park, Jessica Ezell, Geeta Mehta, Abdelrahman Yousif, Linda J. Hong, Ronald J. Buckanovich, Akimasa Takahashi & Ilana Chefetz. (2021) The MEK1/2 Pathway as a Therapeutic Target in High-Grade Serous Ovarian Carcinoma. Cancers 13:6, pages 1369.
Crossref
Crossref
Naresh Golla, Linda J. Hong & Ilana Chefetz. 2021. Detection of Cell Death Mechanisms. Detection of Cell Death Mechanisms
135
147
.
Antons Martincuks, Pei-Chuan Li, Qianqian Zhao, Chunyan Zhang, Yi-Jia Li, Hua Yu & Lorna Rodriguez-Rodriguez. (2020) CD44 in Ovarian Cancer Progression and Therapy Resistance—A Critical Role for STAT3. Frontiers in Oncology 10.
Crossref
Crossref
Jacek R. Wilczyński, Marek Nowak & Miłosz Wilczyński. 2020. Cancer Immunology. Cancer Immunology
487
540
.
Ernest S. Han, Wei Wen, Thanh H. Dellinger, Jun Wu, Selena A. Lu, Richard Jove & John H. Yim. (2018) Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancer. Oncotarget 9:36, pages 24304-24319.
Crossref
Crossref
Carolina Gonzalez-Torres, Javier Gaytan-Cervantes, Karla Vazquez-Santillan, Edna Ayerim Mandujano-Tinoco, Gisela Ceballos-Cancino, Alfredo Garcia-Venzor, Cecilia Zampedri, Paulina Sanchez-Maldonado, Raul Mojica-Espinosa, Luis Enrique Jimenez-Hernandez & Vilma Maldonado. (2017) NF-κB Participates in the Stem Cell Phenotype of Ovarian Cancer Cells. Archives of Medical Research 48:4, pages 343-351.
Crossref
Crossref
Ki-Hyung Kim, Seong-Hwan Park, Kee Hun Do, Juil Kim, Kyung Un Choi & Yuseok Moon. (2016) NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells. Oncotarget 7:44, pages 72148-72166.
Crossref
Crossref
Kohsuke Kanekura, Hirotaka Nishi, Keiichi Isaka & Masahiko Kuroda. (2016) MicroRNA and gynecologic cancers. Journal of Obstetrics and Gynaecology Research 42:6, pages 612-617.
Crossref
Crossref
Andrea M. Patterson, Saghar Kaabinejadian, Curtis P. McMurtrey, Wilfried Bardet, Ken W. Jackson, Rosemary E. Zuna, Sanam Husain, Gregory P. Adams, Glen MacDonald, Rachelle L. Dillon, Harold Ames, Rico Buchli, Oriana E. Hawkins, Jon A. Weidanz & William H. Hildebrand. (2016) Human Leukocyte Antigen–Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer. Molecular Cancer Therapeutics 15:2, pages 313-322.
Crossref
Crossref
Helen Gharwan, Kristen P Bunch & Christina M Annunziata. (2015) The role of reproductive hormones in epithelial ovarian carcinogenesis. Endocrine-Related Cancer 22:6, pages R339-R363.
Crossref
Crossref
Ah-Young KwonGwang-Il KimJu-Yeon JeongJi-Ye SongKyu-Beom KwackChan LeeHae-Youn KangTae-Heon KimJin-Hyung HeoHee Jung An. (2015) VAV3 Overexpressed in Cancer Stem Cells Is a Poor Prognostic Indicator in Ovarian Cancer Patients. Stem Cells and Development 24:13, pages 1521-1535.
Crossref
Crossref
Tiyasha H. Ayub, Mignon-Denise Keyver-Paik, Manuel Debald, Babak Rostamzadeh, Thore Thiesler, Lars Schröder, Winfried Barchet, Alina Abramian, Christina Kaiser, Glen Kristiansen, Walther Kuhn & Kirsten Kübler. (2015) Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer. Oncotarget 6:18, pages 16437-16448.
Crossref
Crossref
Jacek R. Wilczyński & Marek Nowak. 2015. Cancer Immunology. Cancer Immunology
413
456
.
Eleanor Eiffe, Eddy Pasquier, Maria Kavallaris, Cristan Herbert, David StC Black & Naresh Kumar. (2014) Synthesis, anti-cancer and anti-inflammatory activity of novel 2-substituted isoflavenes. Bioorganic & Medicinal Chemistry 22:19, pages 5182-5193.
Crossref
Crossref
Yusaku Watanabe, Kiyoshi Yoshimura, Koichi Yoshikawa, Ryoichi Tsunedomi, Yoshitaro Shindo, Sou Matsukuma, Noriko Maeda, Shinsuke Kanekiyo, Nobuaki Suzuki, Atsuo Kuramasu, Kouhei Sonoda, Koji Tamada, Sei Kobayashi, Hideyuki Saya, Shoichi Hazama & Masaaki Oka. (2014) A stem cell medium containing neural stimulating factor induces a pancreatic cancer stem-like cell-enriched population. International Journal of Oncology.
Crossref
Crossref
Emily K. Colvin. (2014) Tumor-Associated Macrophages Contribute to Tumor Progression in Ovarian Cancer. Frontiers in Oncology 4.
Crossref
Crossref
Tae Hun Kim, Dong Hoon Suh, Mi-Kyung Kim & Yong Sang Song. (2014) Metformin against Cancer Stem Cells through the Modulation of Energy Metabolism: Special Considerations on Ovarian Cancer. BioMed Research International 2014, pages 1-11.
Crossref
Crossref
Juan Carlos Mellídez Barroso & Maria C. Santos. 2014. Stem Cells in Cancer: Should We Believe or Not?. Stem Cells in Cancer: Should We Believe or Not?
263
290
.
Federica Tomao, Anselmo Papa, Luigi Rossi, Martina Strudel, Patrizia Vici, Giuseppe Lo Russo & Silverio Tomao. (2013) Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach. Journal of Experimental & Clinical Cancer Research 32:1.
Crossref
Crossref
Won Duk Joo, Irene Visintin & Gil Mor. (2013) Targeted cancer therapy – Are the days of systemic chemotherapy numbered?. Maturitas 76:4, pages 308-314.
Crossref
Crossref
Furong Dai, Yi Zhang, Xin Zhu, Nianchun Shan & Yuxiang Chen. (2013) The anti-chemoresistant effect and mechanism of MUC1 aptamer–miR-29b chimera in ovarian cancer. Gynecologic Oncology 131:2, pages 451-459.
Crossref
Crossref
Francesca Ricci, Massimo Broggini & Giovanna Damia. (2013) Revisiting ovarian cancer preclinical models: Implications for a better management of the disease. Cancer Treatment Reviews 39:6, pages 561-568.
Crossref
Crossref
Jiabo Di, Tjitske Duiveman-de Boer, Petra L. M. Zusterzeel, Carl G. Figdor, Leon F. A. G Massuger & Ruurd Torensma. (2013) The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients. Cellular Oncology 36:5, pages 363-374.
Crossref
Crossref
Rosemary Foster, Ronald J. Buckanovich & Bo R. Rueda. (2013) Ovarian cancer stem cells: Working towards the root of stemness. Cancer Letters 338:1, pages 147-157.
Crossref
Crossref
Ming Liu, Gil Mor, Huan Cheng, Xue Xiang, Pei Hui, Thomas Rutherford, Gang Yin, David L. Rimm, Jennie Holmberg, Ayesha Alvero & Dan-Arin Silasi. (2013) High Frequency of Putative Ovarian Cancer Stem Cells With CD44/CK19 Coexpression Is Associated With Decreased Progression-Free Intervals In Patients With Recurrent Epithelial Ovarian Cancer. Reproductive Sciences 20:5, pages 605-615.
Crossref
Crossref
G Yin, A B Alvero, V Craveiro, J C Holmberg, H-H Fu, M K Montagna, Y Yang, I Chefetz-Menaker, S Nuti, M Rossi, D-A Silasi, T Rutherford & G Mor. (2012) Constitutive proteasomal degradation of TWIST-1 in epithelial–ovarian cancer stem cells impacts differentiation and metastatic potential. Oncogene 32:1, pages 39-49.
Crossref
Crossref
Dongming Liang, Yuanyuan Ma, Jian Liu, Claes Goran Trope, Ruth Holm, Jahn M Nesland & Zhenhe Suo. (2012) The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells. BMC Cancer 12:1.
Crossref
Crossref
Jun Xia, Changjie Chen, Zhiwen Chen, Lucio Miele, Fazlul H. Sarkar & Zhiwei Wang. (2012) Targeting pancreatic cancer stem cells for cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1826:2, pages 385-399.
Crossref
Crossref
Young Chang Lim, Se-Yeong Oh & Hyunggee Kim. (2012) Cellular characteristics of head and neck cancer stem cells in type IV collagen-coated adherent cultures. Experimental Cell Research 318:10, pages 1104-1111.
Crossref
Crossref
Peter E SchwartzDana M RoqueAlessandro D Santin. 2012. Advances in Ovarian Cancer Management. Advances in Ovarian Cancer Management
136
154
.
Ayesha B. Alvero, Michele K. Montagna, Vinicius Craveiro, Lanzhen Liu & Gil Mor. (2011) Distinct Subpopulations of Epithelial Ovarian Cancer Cells Can Differentially Induce Macrophages and T Regulatory Cells Toward a Pro‐Tumor Phenotype. American Journal of Reproductive Immunology 67:3, pages 256-265.
Crossref
Crossref
Donavon Hiss. (2012) Optimizing Molecular-Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways. Journal of Oncology 2012, pages 1-23.
Crossref
Crossref
Michael Craig, Michael Schumacher & Yana Zavros. 2012. Helicobacter Species. Helicobacter Species
227
238
.
Karina Dahl Steffensen, Ayesha B. Alvero, Yang Yang, Marianne Waldstrøm, Pei Hui, Jennie C. Holmberg, Dan-Arin Silasi, Anders Jakobsen, Thomas Rutherford & Gil Mor. (2011) Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer. Journal of Oncology 2011, pages 1-12.
Crossref
Crossref